Bruce Blazar, M.D.
Dr. Blazar is a Regent’s Professor in the Department of Pediatrics in the Division of Blood and Marrow Transplantation (BMT). He is also an Associate Vice President of the Academic Health Center and attends on the BMT service. He is the director of the Center for Translational Medicine, created to bring innovative early-phase therapies into the clinic.
“My current focus is to get early-phase therapies into the clinic. Areas that are currently under investigation include: prevention of graft-versus-host-disease, a common side-effect after blood or marrow transplantation; development of new strategies to enhance immune recovery after transplantation; prevention of tumor and leukemia relapse; and gene therapy and tissue repair.”
Committed to finding a cure
“Although some types of childhood cancer can be readily treated using chemotherapy drugs alone, other types will need innovative approaches that are developed from the laboratory. When I began my career in pediatric oncology and blood and marrow transplantation, it was with the hope and expectation that I might make a difference by investigating the basic principles needed for treating childhood cancers and translating those into the clinic.”
Children's Cancer Research Fund: Making a difference
“Children's Cancer Research Fund has had a tremendous impact on my research, providing the critical seed money needed to develop innovative concepts and approaches for childhood cancer therapy and then translating these concepts to the clinic. Children's Cancer Research Fund has enabled our division and program to create a powerful team dedicated to treating childhood cancer using all available techniques and approaches. Without question, Children's Cancer Research Fund is a major reason that we have been successful in accomplishing this goal and for remaining at the University of Minnesota to continue these efforts.”